# Amgen Inc. (AMGN) — Q4-2020 Earnings Results

**Report date:** 2021-02-02 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2020

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 0.02%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.81 | N/A | +13.43% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management highlighted the positive EPS surprise as a sign of resilience. They emphasized their commitment to innovation and future growth.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> The company remains focused on its long-term growth strategy.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Amgen's earnings report showed a strong EPS performance, exceeding expectations, which led to a slight increase in the stock price. However, the lack of revenue figures and guidance may leave investors cautious. The minimal stock reaction suggests that the market was already anticipating a solid EPS result.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2020_